Evonik Industries AG
EVKIY · Other OTC · USD
11,46USD
−0,37 (−3,11 %)Stand 10. Nov., 17:44
Kennzahlen
- Eröffnung
- 11,56
- Vortag
- 11,83
- Tagesspanne
- 11,46 – 11,56
- 52 Wochen
- 7,24 – 12,22
- Volumen
- 863
- Ø Volumen
- 17.923
- Börsenwert
- 10,68 Mrd. $
- KGV
- 54,9
- Gewinn je Aktie (TTM)
- 0,19
- Dividendenrendite
- 4,8 %
- Beta
- 0,4
- Nächste Zahlen
- –
Finanzen
| EUR | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Umsatz | 14,07 Mrd. | 15,16 Mrd. | 15,27 Mrd. | 18,49 Mrd. | 14,96 Mrd. |
| Herstellungskosten | 10,83 Mrd. | 11,42 Mrd. | 11,88 Mrd. | 14,26 Mrd. | 10,93 Mrd. |
| Bruttogewinn | 3,24 Mrd. | 3,74 Mrd. | 3,39 Mrd. | 4,23 Mrd. | 4,03 Mrd. |
| Forschung und Entwicklung | 418 Mio. | 459 Mio. | 443 Mio. | 460 Mio. | 464 Mio. |
| Vertrieb und Verwaltung | 2,21 Mrd. | 2,67 Mrd. | 2,33 Mrd. | 2,59 Mrd. | 2,26 Mrd. |
| Operatives Ergebnis | 641 Mio. | 639 Mio. | 630 Mio. | 1,43 Mrd. | 1,24 Mrd. |
| EBITDA | 1,84 Mrd. | 1,76 Mrd. | 991 Mio. | 2,08 Mrd. | 2,18 Mrd. |
| Nettogewinn | 265 Mio. | 222 Mio. | −465 Mio. | 540 Mio. | 746 Mio. |
| Gewinn je Aktie (verwässert) | 0,28 | 0,24 | -0,50 | 0,58 | 0,80 |
Bewertung
Letzte 12 Monate
- KGV
- 54,9
- Kurs-Umsatz-Verhältnis
- 0,7
- Kurs-Buchwert-Verhältnis
- 1,2
- PEG
- 0,6
- Bruttomarge
- 23,2 %
- Operative Marge
- 8,5 %
- Nettomarge
- 1,2 %
- Verschuldungsgrad
- 0,5
- EV/EBITDA
- 5,6
- Eigenkapitalrendite
- 2,2 %
- Kapitalrendite (ROIC)
- 5,3 %
- Free-Cashflow-Rendite
- 9,5 %
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |
|---|---|---|---|---|---|
| Bruttomarge | 23,1 % | 24,7 % | 22,2 % | 22,9 % | 26,9 % |
| Operative Marge | 4,6 % | 4,2 % | 4,1 % | 7,7 % | 8,3 % |
| Nettomarge | 1,9 % | 1,5 % | −3,0 % | 2,9 % | 5,0 % |
| KGV | 23,7 | 35,4 | -18,0 | 15,9 | 17,4 |
| Kurs-Umsatz-Verhältnis | 0,4 | 0,5 | 0,5 | 0,5 | 0,9 |
| Kurs-Buchwert-Verhältnis | 0,8 | 0,9 | 0,9 | 0,8 | 1,4 |
| Verschuldungsgrad | 0,5 | 0,4 | 0,5 | 0,4 | 0,4 |
| Liquidität 3. Grades | 1,5 | 1,4 | 1,5 | 1,8 | 1,5 |
| Dividendenrendite | 8,8 % | 6,9 % | 6,5 % | 6,4 % | 4,1 % |
| Unternehmenswert | 9,57 Mrd. | 11,22 Mrd. | 11,88 Mrd. | 12,16 Mrd. | 16,16 Mrd. |
| EV/EBITDA | 5,2 | 6,4 | 12,0 | 5,9 | 7,4 |
| Eigenkapitalrendite | 3,3 % | 2,5 % | −5,2 % | 4,9 % | 8,0 % |
| Kapitalrendite (ROIC) | 2,8 % | 2,1 % | 3,5 % | 4,7 % | 4,7 % |
| Free-Cashflow-Rendite | 11,2 % | 11,1 % | 9,6 % | 9,1 % | 7,2 % |
Wachstum
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | |
|---|---|---|---|---|---|
| Umsatz | −7,2 % | −0,7 % | −17,4 % | +23,6 % | +22,6 % |
| Bruttogewinn | −13,2 % | +10,2 % | −19,9 % | +5,0 % | +19,7 % |
| Operatives Ergebnis | +0,3 % | +1,4 % | −55,8 % | +14,9 % | +40,1 % |
| Nettogewinn | +19,4 % | +147,7 % | −186,1 % | −27,6 % | +60,4 % |
| Gewinn je Aktie | +16,7 % | +148,0 % | −186,2 % | −27,5 % | +50,9 % |
| Freier Cashflow | −20,4 % | +9,0 % | +2,0 % | −15,5 % | +20,5 % |
| Dividende je Aktie | −0,3 % | +0,3 % | 0,0 % | +1,7 % | 0,0 % |
Analysten
Einstufungen · Hold
- 0Stark kaufen
- 0Kaufen
- 1Halten
- 0Verkaufen
- 0Stark verkaufen
Kursziel
Gerade nicht verfügbar.
Schätzungen
| FY 2026 | FY 2027 | |
|---|---|---|
| Umsatz (Ø) | 14,93 Mrd. | 14,69 Mrd. |
| Umsatz (Tief – Hoch) | 14,68 Mrd. – 15,12 Mrd. | 14,44 Mrd. – 14,88 Mrd. |
| Gewinn je Aktie (Ø) | 0,91 | 0,61 |
| Gewinn je Aktie (Tief – Hoch) | 0,89 – 0,93 | 0,60 – 0,62 |
| Analysten | 1 | 1 |
Letzte Änderungen
- Citigroup15. Nov. 2018Buy → Neutral
Quartalszahlen
| Mai 2026 | März 2026 | Aug. 2025 | Mai 2025 | März 2025 | Nov. 2024 | Aug. 2024 | Mai 2024 | |
|---|---|---|---|---|---|---|---|---|
| Gewinn je Aktie · Erwartet | – | – | – | – | – | – | – | – |
| Gewinn je Aktie · Tatsächlich | 0,16 | 0,02 | 0,15 | 0,55 | -0,34 | 0,54 | -0,01 | 0,36 |
| Abweichung | – | – | – | – | – | – | – | – |
| Umsatz · Tatsächlich | 3,94 Mrd. | 4 Mrd. | 4,12 Mrd. | 4,14 Mrd. | 3,73 Mrd. | 4,28 Mrd. | 4,23 Mrd. | 4,08 Mrd. |
Dividenden und Splits
| Ex-Tag | Zahltag | Betrag |
|---|---|---|
| 5. Juni 2026 | 24. Juni 2026 | 0,58 |
| 30. Mai 2025 | 17. Juni 2025 | 0,67 |
| 6. Juni 2024 | 24. Juni 2024 | 0,63 |
| 1. Juni 2023 | 20. Juni 2023 | 0,62 |
| 26. Mai 2022 | 13. Juni 2022 | 0,63 |
| 3. Juni 2021 | 22. Juni 2021 | 0,70 |
| 2. Sept. 2020 | 18. Sept. 2020 | 0,34 |
Aktiensplits
–
Eigentümer
Institutionen
Gerade nicht verfügbar.
Insider-Geschäfte
–
Vergleichbare Unternehmen
Über das Unternehmen
Evonik Industries AG is a prominent company specializing in the field of chemical production. Its operations are divided into five principal business segments: Specialty Additives, Nutrition & Care, Smart Materials, Performance Materials, and Technology & Infrastructure. The Specialty Additives division is responsible for supplying a variety of advanced chemical compounds, such as polyurethane enhancers, organically modified silicones, isophorones, epoxy curing agents, oil performance additives, fumed silicas, matting agents, TAA and its derivatives, and acetylenic diol-based surfactants. These offerings are crucial for consumer products and a wide range of specific industrial applications. The Nutrition & Care segment is dedicated to providing life science ingredients, including amphoteric surfactants, ceramides, phytosphingosines, oleochemical compounds, quaternary derivatives, various amino acids and their derivatives, synthesis products, pharmaceutical-grade polymers, and DL-methionine. These components are vital for consumer goods, animal nutrition, and healthcare products. Under its Smart Materials umbrella, Evonik offers an extensive portfolio of cutting-edge materials. This includes hydrogen peroxide, peracetic acid, a diverse array of catalysts (such as activated nickel, precious metal powder, and those for oil and fat hydrogenation), amorphous polyalphaolefins, polybutadienes, various resins (polyester, thermoplastic, and reactive methacrylate), PEEK, polyamide 12, organosilanes, chlorosilanes, fumed silicas, fumed metal oxides, and precipitated silicas. These materials are utilized across numerous sectors, including automotive, paints, coatings, adhesives, construction, and many others. The Performance Materials segment concentrates on manufacturing essential polymer materials and chemical intermediates. Its product lineup features butene-1, DINP, isononanol, cyanuric chloride, alkoxides, and superabsorbent polymers, serving the rubber, plastics, and automotive industries. Lastly, the Technology & Infrastructure division furnishes a range of essential services, encompassing site management, utility and waste handling, technical support, process technology development, engineering, and logistics solutions. Evonik maintains a global operational footprint, conducting business across the Asia-Pacific region, Europe, the Middle East, Africa, Central and South America, and North America. The company, established in 1873 and headquartered in Essen, Germany, operates as a subsidiary of the RAG-Stiftung.
Führung
- Christian KullmannChief Executive Officer & Chairman of the Executive Board
- Michael RauchChief Financial Officer & Member of Executive Board
- Thomas WesselChief Human Resources Officer, Labor Relations Director & Member of Executive Board
- Lauren KjeldsenChief Operating Officer of Custom Solutions & Member of the Management Board
- Claudine MollenkopfChief Operating Officer of Advanced Technologies & Member of the Management Board
- Tim LangeHead of Investor Relations
- CEO
- Claus Rettig
- Mitarbeitende
- 31.053
- Hauptsitz
- Essen, NW, DE
- Sektor
- Basic Materials
- Branche
- Chemicals - Specialty
- Börsengang
- 8. Jan. 2021
- Website
- evonik.com
Nachrichten
Kurse mindestens 15 Minuten verzögert. Daten: Financial Modeling Prep. Keine Anlageberatung.